PUBLICACIÓN
Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: The potential value of the PEPs study
Mas S.; Llerena A.; Saiz J.; Bernardo M.; Lafuente A.
2012 PHARMACOGENOMICS
Genetics (Q3), Molecular Medicine (Q2), Pharmacology (Q2)
JCR: 3.857
SJR: 0.968
CITAS
16
DOI
10.2217/pgs.12.159
EID
2-s2.0-84869995013
ISSN
1462-2416
EISSN
1744-8042
BIBTEX
@article { author = {Mas S and Llerena A and Saíz J and Bernardo M and Lafuente A}, title = {Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.}, year = {2012}, month = {nov}, url = {http://europepmc.org/abstract/med/23171340}, doi = {10.2217/pgs.12.159} }
AUTORES DE LA UEX
